At the Annual General Meeting of HBM Healthcare Investments AG on 23 June 2025, shareholders approved a new share buyback programme for a maximum of 674,000 shares (corresponding to 10% of the shares registered in the commercial register) for the purpose of cancellation through a capital reduction.

The buyback programme will be carried out via a separate trading line on the SIX Swiss Exchange, with Zürcher Kantonalbank being entrusted with this task. The programme is scheduled to commence on Friday, 4 July 2025 and is expected to conclude on 3 July 2028 at the latest.

Further information on the new 2025 buyback programme is available on the company website at https://www.hbmhealthcare.com/en/investors/information.

Contact
For further information, please contact Dr Andreas Wicki on +41 41 710 75 77, or at andreas.wicki@hbmhealthcare.com.